Sector portfolio · VC firm · Switzerland
HBM Healthcare Investments' Biotech portfolio
HBM Healthcare Investments has backed 10 Biotech startups in rounds we track, $1.5B between them, shown by the stage each has reached. The best-funded is Dren Bio.
Funding by segment
- Series C and later$558M5
- Stage not reported$627M3
- Series B$343M2
Where they are based
- United States9$1.3B
- China1$181M
United States
ChinaFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M2
- $50M to $250M6
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
8 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- China1
Startups by country, 2 countries in all.
Segment by segment
Series C and later
5 startups · $558M raised
Nuance PharmaNuance Pharma is a specialty biopharmaceutical company based in Shanghai, founded in 2014 by Mark Lotter.China$181M
Kolltan PharmaceuticalsKolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.United States$146M
FORE BiotherapeuticsFore Biotherapeutics is a clinical-stage precision oncology company based in Philadelphia, PA.United States$108M
AnaptysBioAnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing United States$85M- ITIconic TherapeuticsUnited States$38M
Stage not reported
3 startups · $627M raised
Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M- YYmAbsUnited States$80M
Series B
2 startups · $343M raised
- VBViela BioViela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.United States$325M
- BBaseHealthBaseHealth is a next-generation health care analytics company for top health systems and Medicare Advantage plans focused on applyUnited States$18M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names HBM Healthcare Investments as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like HBM Healthcare Investments?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.